Biomedical Engineering Reference
In-Depth Information
Meistrich ML, Chawla SP, Da Cunha MF, Johnson SL, Plager C, Papadopoulos NE, Lipshultz LI
& Benjamin RS 1989 Recovery of sperm production after chemotherapy for osteosarcoma.
Cancer
63
2115-2123.
Meistrich ML, Wilson G, Brown BW, Da Cunha MF & Lipshultz LI 1992 Impact of cyclophos-
phamide on long-term reduction in sperm count in men treated with combination chemother-
apy for Ewing and soft tissue sarcomas.
Cancer
70
2703-2712.
Meistrich ML, Parchuri N, Wilson G, Kurdoglu B & Kangasniemi M 1995 Hormonal protection
from cyclophosphamide-induced inactivation of rat stem spermatogonia.
J. Androl.
16
334-341.
Meistrich ML, Wilson G, Mathur K, Fuller LM, Rodriguez MA, McLaughlin P, Romaguera JE,
Cabanillas FF, Ha CS, Lipshultz LI & Hagemeister FB 1997a Rapid recovery of spermatogen-
esis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's
disease.
J. Clin. Oncol.
15
3488-3495.
Meistrich ML, Wilson G, Zhang Y, Kurdoglu B & Terry NH 1997b Protection from procarbazine-
induced testicular damage by hormonal pretreatment does not involve arrest of spermatogonial
proliferation.
Cancer Res.
57
1091-1097.
Meistrich ML, Wilson G & Huhtaniemi I 1999 Hormonal treatment after cytotoxic therapy stimu-
lates recovery of spermatogenesis.
Cancer Res.
59
3557-3560.
Meistrich ML, Wilson G, Kangasniemi M & Huhtaniemi I 2000 Mechanism of protection of rat
spermatogenesis by hormonal pretreatment: stimulation of spermatogonial differentiation after
irradiation.
J. Androl.
21
464-469.
Meistrich ML, Wilson G, Shuttlesworth G, Huhtaniemi I & Reissmann T 2001 GnRH agonists
and antagonists stimulate recovery of fertility in irradiated LBNF1 rats.
J. Androl.
22
809-817.
Meistrich ML, Vassipopoulou-Sellin R & Lipshultz LI 2005 Gonadal dysfunction. In
Cancer:
Principles and Practice of Oncology
, pp. 2560-2574. Eds VT DeVita, S Hellman & SA
Rosenberg. Philadelphia: Lippincott, Williams & Wilkins.
Morris ID & Shalet SM 1990 Protection of gonadal function from cytotoxic chemotherapy and
irradiation.
Baillieres Clin. Endocrinol. Metab.
4
97-118.
Nagano M, McCarrey JR & Brinster RL 2001 Primate spermatogonial stem cells colonize mouse
testes.
Biol. Reprod.
64
1409-1416.
Nonomura M, Okada K, Hida S & Yoshida O 1991 Does a gonadotropin-releasing hormone ana-
logue prevent cisplatin-induced spermatogenic impairment? An experimental study in the
mouse.
Urol. Res.
19
135-140.
Oakberg EF 1957 Gamma-ray sensitivity of spermatogonia of the mouse.
J. Exp. Zool.
134
343-356.
Oakberg EF & Diminno RL 1960 X-ray sensitivity of primary spermatocytes of the mouse.
Int. J.
Radiat. Biol.
2
196-209.
Ogawa T, Dobrinski I & Brinster RL 1999 Recipient preparation is critical for spermatogonial
transplantation in the rat.
Tissue Cell
31
461-472.
Parchuri N, Wilson G & Meistrich ML 1993 Protection by gonadal steroid hormones against
procarbazine-induced damage to spermatogenic function in LBNF1 hybrid rats.
J. Androl.
14
257-266.
Paulsen CA 1973 The study of radiation effects on the human testis: including histologic, chro-
mosomal and hormonal aspects. Final progress report of AEC contract AT(45-1)-2225, Task
Agreement 6. RLO-2225-2. U.S. Department of Energy.
Pegg DG, Watkins JR, Graziano MJ & McKenna MJ 1996 Subchronic intravenous toxicity of the
antineoplastic drug, amsacrine, in male Wistar rats.
Fundam. Appl. Toxicol.
32
45-52.
Potashnik G & Porath A 1995 Dibromochloropropane (DBCP): a 17-year reassessment of testicu-
lar function and reproductive performance.
J. Occup. Environ. Med.
37
1287-1292.
Pryzant RM, Meistrich ML, Wilson G, Brown B & McLaughlin P 1993 Long-term reduction in
sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lym-
phomas.
J. Clin. Oncol.
11
239-247.
Search WWH ::
Custom Search